EARNINGS PER SHARE News & Analysis

Gaming products a bright spot amid lost China revenues.

We continue to view the stock as materially undervalued.

Both of these moated companies annouced solid enough results, but our analysts continue to think the shares are too expensive.

The ASX's biggest healthcare name saw its shares fall after reporting first-half results.

There is a veritable alphabet soup of financial ratios that many investors struggle to comprehend and interpret effectively. 

These stocks are still cheap despite impressive earnings. 

We raise our fair value after strong results but shares are pricey.

We believe the company is in a transition year and results will improve.

We look at the biggest market reactions in our coverage and what our analysts think about the companies.

Guzman's business has made an impressive start to the new fiscal year. We still have our doubts on valuation levels.